Indivior Pharmaceuticals (INDV) Change in Cash (2024 - 2026)

Indivior Pharmaceuticals' Change in Cash history runs 3 years deep, the most recent figure standing at -$20.0 million for Q1 2026.

• In Q1 2026, Change in Cash fell 137.74% year-over-year to -$20.0 million; the TTM figure through Mar 2026 stood at -$197.0 million (down 258.87% YoY), while the FY2025 annual figure was -$124.0 million, down 4233.33% from the prior year.
• Change in Cash was -$20.0 million for Q1 2026 at Indivior Pharmaceuticals, up from -$252.0 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $136.0 million in Q2 2025 to a low of -$252.0 million in Q4 2025.
• Historically, Change in Cash has averaged -$15.7 million across 3 years, with a median of -$14.0 million in 2024.
• Biggest YoY gain for Change in Cash was 177.94% in 2025; the steepest drop was 912.9% in 2025.
• A 3-year view of Change in Cash shows it stood at $31.0 million in 2024, then plunged by 912.9% to -$252.0 million in 2025, then jumped by 92.06% to -$20.0 million in 2026.
• The last three Change in Cash figures came in at -$20.0 million (Q1 2026), -$252.0 million (Q4 2025), and -$61.0 million (Q3 2025), per Business Quant data.